Forms of CTCL that express CD8+ phenotype in humans have been reported (38): in some rare cases, well-defined types of CTCL (such as MF) express CD8+ and have similar clinical presentation and disease prognosis as the more common CD4+ cases (45). The gene discussed is CD8A; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.